Biovolen

Biovolen is a German skincare brand owned by Evertz Pharma GmbH, a privately held maker of cosmetics and food supplements based in Frankfurt am Main [1]. Its range is built from ointments, called "Salben" in German, each centred on a single active of natural origin and aimed at one visible skin concern, from wrinkles and pigment spots to cellulite and spider veins. The brand's tagline, "Anti-Aging aus der Natur", translates as anti-ageing from nature.

The line began in 2019 with the Biovolen Aktiv Moossalbe, an anti-wrinkle ointment for mature skin based on an extract of cultured moss, and was later widened into a family of similar single-purpose products. Biovolen is sold mainly through pharmacies and through its own online shops, and it remains active.

Biovolen grew out of one product. In the company's account of the Moossalbe, the aim was a care product with actives of natural origin that could be used as supportive care for wrinkles and that would also be stocked by pharmacies. That pharmacy ambition has shaped the brand ever since: the ointments sold in pharmacies each carry a German pharmacy product number, and they are distributed through pharmacy wholesalers.

No individual founder of Biovolen is publicly named. The brand is presented throughout as a product of Evertz Pharma, whose managing director is Dominik Evertz. The parent describes itself as a team of specialists and researchers who develop cosmetics and supplements, working with natural raw materials that it processes using biotechnological methods. Its mission statement, which also appears on the Biovolen website, says the company starts outside classical medicine and concentrates on the causes of a problem rather than its symptoms [4].

Almost every date in Biovolen's early history comes from the company itself, and its own account is not fully consistent. The Moossalbe product page states that the ointment was brought to market in 2019, and it cites a filing for the word mark "Biovolen" with the German Patent and Trade Mark Office (DPMA) dated 21 August 2019 [8]. A history section on the same page, however, says the ointment was developed in 2020 for the care of mature skin [8]. The 2020 date cannot be reconciled with a launch in the previous year, and this article follows 2019, which the dated trademark filing supports. The brand also points to its moossalbe.de domain, registered in 2019, and to search-interest data as evidence of when the product first appeared.

In October 2020 the company filed a three-dimensional trademark for "Biovolen Aktiv Moossalbe", a type of registration that protects the look of a product rather than only its name. In 2021, according to the brand, the television presenter Birgit Schrowange became its official ambassador, and she continues to feature prominently on the Biovolen website.

The company says the line was extended with further ointments after the success of the Moossalbe. Biovolen does not publish launch dates for the individual products, but the later additions follow the same pattern: a single named active for a single skin concern.

Biovolen belongs to Evertz Pharma GmbH, headquartered in Frankfurt am Main. The parent runs a small portfolio of similarly focused brands; its corporate website lists Rezilin, Citurin, Retixol, Vitalrin, Hyaluxon and Scortin alongside Biovolen [2]. Rezilin is a basil-extract hair treatment for thinning and brittle hair, Citurin is a mandarin-extract tincture marketed for grey hair, and Vitalrin is a capsule supplement intended to support weight loss. Evertz Pharma says all of its products are made in Germany.

The parent company has drawn attention outside the beauty trade for the way it manages its cash. In June 2025, Bitcoin Magazine reported, citing a press release, that Evertz Pharma had bought 100 bitcoin in May 2025, worth roughly €10 million, and described it as the first company in Germany to adopt a strategic Bitcoin reserve [10]. The reserve began in December 2020 with an initial purchase of €2 million, and the company has since put part of its profits into Bitcoin on a regular basis. Dominik Evertz tied the policy to the company's mission "to promote natural beauty on a scientific foundation", while Group CFO Tobias Evertz said the company would keep investing profits in Bitcoin. The report noted that, unlike several better-known corporate Bitcoin holders, Evertz Pharma is privately owned.

Biovolen describes its approach as combining selected actives of natural origin with modern development and controlled production in Germany. The organising idea is specialisation. Rather than a cleanser-to-moisturiser routine, the range offers one ointment per problem, each named after its main ingredient: moss for wrinkles, cress for pigment spots, mustard for cellulite. The parent company sums up its own values in three words: innovation, naturalness and people at the centre.

The brand positions the ointments as premium products and makes several formulation pledges. According to Biovolen, its products contain no mineral oil, microplastics or silicones, and all the oils it uses come from controlled organic farming [7]. Evertz Pharma adds that its raw materials are grown without genetic engineering, chemical pesticides or mineral fertilisers. The organic wording refers to how the oils are farmed; no organic certification of the finished products is documented.

On animal welfare the two company websites differ slightly. Evertz Pharma's own about page says that all of its products except the Honigsalbe, a honey-based ointment, are fully vegan and not tested on animals [3]. The Moossalbe website goes further and states that no animal-derived substances are used in making or developing Biovolen, without mentioning that exception [7]. No third-party cruelty-free certification is documented for the brand.

The company also describes a set of social and environmental commitments. It says part of its proceeds goes to the German nature-conservation charity NABU, to sheltered workshops for people with disabilities and to the German Red Cross. Biovolen jars are made of thin, recyclable plastic rather than glass, and the brand says it deliberately does without pre-made display stands for pharmacies.

The Moossalbe remains the brand's flagship product and the one on which most of its scientific claims rest. Its active ingredient is derived from Physcomitrella patens, a moss grown in culture, and the brand identifies phytol as a key compound in the extract. To make the moss usable in skincare, Biovolen says it developed its own extraction method, which it has trademarked as Phyto-Lyse [7]. According to the company, the resulting active supports the skin's natural resilience and counters premature skin ageing. The Moossalbe website supports this with a reference list that includes a 2018 paper by F. Wandrey, B. Henes, F. Zülli and R. Reski titled "Biotechnologically Produced Moss Active Improves Skin Resilience", and it names the Skin Test Institute in Neuchâtel, Switzerland.

Biovolen also reports safety testing. The skin tolerance of the Moossalbe, the company says, was tested and confirmed by the independent institute DermaTest [8], and it cites a patch test on human volunteers carried out by an independent German contract research institute. Evertz Pharma states more broadly that it works with independent dermatological institutes and that its production sites are certified under the strict rules that apply to manufacturing medical devices. The Moossalbe is, according to the brand, developed, produced and shipped entirely in Germany, not merely filled there. The company also publishes a customer-satisfaction figure from its own online shop; this is a self-reported survey, not a clinical result.

Around the Moossalbe, the current range covers a series of single concerns:

- Kressesalbe (cress): pigment and age spots on the face, décolleté, arms and hands - Jasminsalbe (jasmine): dark circles and hooded eyelids - Harzsalbe (resin): large pores and blackheads - Senfsalbe (mustard): cellulite and dimpling on the arms and legs - Algensalbe (algae): spider veins - Hefesalbe (yeast): rough, bumpy skin, known in German as "Reibeisenhaut" - Pfeffersalbe (pepper): a self-tanner for pale skin - Meersalbe (sea): care for hands and nails

Exactly how many ointments make up the line depends on which company page is consulted. Biovolen's information page for pharmacies lists eight ointments, each with its own pharmacy product number [5]. The online shop adds the Meersalbe as a ninth. Evertz Pharma's about page and the structured data on the Biovolen homepage, meanwhile, refer to ten ointments, including a Kaktussalbe for dry, flaky facial skin and a Honigsalbe for itchy and irritated skin. Neither of these two appears in the current Biovolen shop, and the company has not said whether they have been discontinued.

Independent coverage of the products is scarce. In May 2022 the website of the regional newspaper Westfälische Nachrichten ran a sponsored special feature on the Moossalbe, published under the name of its media group, Aschendorff Medien. Among other things, it stated that the German consumer-testing organisation Stiftung Warentest had not tested the ointment and that no official test verdict existed [9].

Biovolen is active. Its online shop and its "Wissenswertes" (good to know) blog were updated through September and October 2026; the most recent post, dated 9 October 2026, discusses care mistakes to avoid with dry skin in winter [6]. The ointments are sold in pharmacies through wholesalers in Germany and Austria and through the brand's own websites, biovolen.de and moossalbe.de, and the brand's communication is almost entirely in German.